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Abstract
Objectives: Visual contrast detection thresholds and suprathreshold contrast discrimination thresholds were compared to luminance and
¯ash/pattern electroretinograms (ERG) and visually evoked potentials (VEP) in patients with Parkinson's disease (n  31), patients with
multiple system atrophy (n  6), patients with progressive supranuclear palsy (n  6) and control patients without central nervous disease
(n  33).
Methods: The stimuli were luminance modulated full-®eld (¯ash) or horizontally oriented sinewave gratings (pattern), the latter having
either a low (0.5 cycles/deg) or medium (4.0 cycles/deg) spatial frequency. Stimulus contrast ranged from 10 to 80% so that contrast response
functions could be derived.
Results: Contrast thresholds were higher in the patients with Parkinson's disease than in the control patients. Contrast discrimination
thresholds were also somewhat elevated in patients with Parkinson's disease. Pattern ERG amplitudes were signi®cantly reduced in patients
with Parkinson's disease for the medium spatial frequency stimulus, but less for the low spatial frequency and ¯ash stimuli.
Conclusions: Our results suggest that Parkinson's disease impairs contrast processing in the retina. VEP amplitudes did not signi®cantly
differ between the groups for the conditions tested. Patients with progressive supranuclear palsy also showed impaired contrast perception
and reduced ERG amplitudes, whereas patients with multiple system atrophy were less impaired. q 2000 Elsevier Science Ireland Ltd. All
rights reserved.
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1. Introduction
There is substantial evidence that Parkinson's disease is
associated with visual impairments. These impairments are
usually thought to be a result of an attenuation of the retinal
signal at an early stage in the visual process. Electrophysio-
logical evidence of visual pathology has been related to
delays in visually evoked potentials (Bodis-Wollner and
Yahr, 1978; Delwaide, 1980; Gawel, 1981; Marx et al.,
1986), as well as amplitude reductions in the pattern-elec-
troretinogram (Ghilardi et al., 1989; Ikeda et al., 1994).
Psychophysically-de®ned contrast detection thresholds are
also elevated in patients with Parkinson's disease (Bodis-
Wollner et al., 1987; Bodis-Wollner, 1990; Mestre et al.,
1990, 1992; Masson et al., 1993). The selective nature of the
visual impairments (medium-to-high spatial frequencies
and medium temporal frequencies; (Marx et al., 1986;
Bodis-Wollner et al., 1987)) suggests the involvement of
speci®c mechanisms underlying the transfer of pattern
contrast. The presence of normal pattern adaptation effects
(Tebartz Van Elst et al., 1997) suggests that function in the
visual cortex remains intact.
Dopamine is an important neurotransmitter in the visual
pathway (Bodis-Wollner et al., 1987). The presence of
dopamine in the mammalian retina has been well documen-
ted (Haggendal and Malmfors, 1963; Dowling and Ehinger,
1975; Mariani et al., 1984; Massey and Redburn, 1987;
Nguyen-Legros et al., 1988; Skrandies and WaÈssle, 1988),
including the human retina (Frederick et al., 1982). In addi-
tion to the loss of dopaminergic neurons in the pars
compacta of the substantia nigra, Parkinson's disease has
also been associated with a reduction in the level of dopa-
mine in the retina (Harnois and Di Paolo, 1990). There is
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some evidence that dopamine might also act at synapses in
the lateral geniculate nucleus (Papadopoulos and Parnave-
las, 1990) and the visual cortex (Reader and Quesney, 1986;
Parkinson, 1989). Thus, dopaminergic activity in the visual
system could be diminished in Parkinson's disease.
In an attempt to identify the neural mechanisms under-
lying the impairment in contrast vision in Parkinson's
disease, we recorded electroretinograms (ERGs) and
visually evoked potentials (VEPs) in 31 patients with
Parkinson's disease. Parallel determination of the contrast
detection and discrimination thresholds for two spatial
frequencies and ®ve contrast levels was also conducted.
We could therefore evaluate the extent to which changes
in electrophysiological measurements are associated with
concomitant changes in visual performance. The results
from patients with Parkinson's disease are compared to
those from 33 control patients and 12 patients with related
neurodegenerative diseases (6 patients with multiple system
atrophy, 6 patients with supranuclear palsy) to determine the
extent to which the measured changes are speci®c to this
neurodegenerative disorder.
2. Materials and methods
2.1. Subjects
Table 1 gives a description of the 3 patient groups. All
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Table 1
Clinical data on the patients with Parkinson's disease (PD), multiple system atrophy (MSA) and progressive supranuclear palsy (PSP)
Patient Gender Age Webster Medication
l-Dopa (mg)
Acuity right
eye/left eye
Other
PD01 F 64 4 ,500 0.6/0.8 ±
PD02 M 47 2 ,500 1.0/1.0 ±
PD03 F 70 11 ,750 0.5/0.5 ±
PD04 F 48 4 ,375 0.9/1.0 ±
PD05 M 66 8 .750 0.8/0.8 ±
PD06 M 69 15 ,375 0.6/0.0 Amaurosis left
PD07 M 63 4 ,750 1.0/0.9 ±
PD08 M 57 6 .750 0.8/0.8 ±
PD09 F 54 5 ,750 1.2/1.2 ±
PD10 M 56 10 Untreated 0.7/0.4 ±
PD11 M 71 17 .750 0.9/0.9 ±
PD12 F 63 24 ,750 0.6/0.9 ±
PD13 M 65 11 .750 0.6/0.8 ±
PD14 F 68 9 ,750 1.0/1.0 ±
PD15 M 62 11 .750 1.0/1.0 ±
PD16 M 37 2 Untreated 1.2/1.1 ±
PD17 M 55 14 ,750 0.8/0.8 ±
PD18 M 64 8 ,500 1.0/1.0 ±
PD19 F 44 9 ,500 1.0/1.0 ±
PD20 M 46 11 ,750 1.0/1.0 ±
PD21 F 40 8 ± 1.0/1.0 ±
PD22 M 67 14 ,500 1.0/1.0 ±
PD23 F 55 6 Untreated 1.0/1.0 ±
PD24 F 70 18 .750 0.8/± Central venous thrombosis left
PD25 M 56 9 ,500 1.0/1.0 ±
PD26 M 37 2 ± 1.0/1.0 ±
PD27 M 79 15 ,750 0.7/0.8 ±
PD28 M 59 11 ,500 0.8/0.8 ±
PD29 F 72 9 ,375 1.0/1.0 ±
PD30 M 68 17 ,500 0.8/0.8 ±
±
MSA01 M 54 11 ,500 1.0/1.0 ±
MSA02 F 63 19 .750 0.8/0.7 ±
MSA03 F 59 22 Untreated 1.0/1.0 ±
MSA04 F 57 23 ,750 0.8/0.7 ±
MSA05 M 66 10 Untreated 0.4/0.9 Ocular hypertension
MSA06 F 56 23 ,500 1.0/1.0 ±
±
PSP01 M 75 4 ,750 0.8/0.8 ±
PSP02 F 68 ± , 375 0.7/0.5 Fixational nystagmus
PSP03 M 68 25 ,750 1.0/0.5 ±
PSP04 M 61 10 Untreated 0.8/0.7 ±
PSP05 F 69 7 ,750 1.0/1.0 Arti®cial lens
PSP06 M 69 19 ,500 0.8/0.8 ±
patients were recruited from the in-patient clinic of the
Neurology Department after being informed about the
general aims of the investigation. Participation was on a
voluntary basis and only occurred after informed consent.
Approval for the study was obtained from the local ethical
board of the University of Freiburg. Patients with any addi-
tional CNS or eye disease were excluded from the study.
The clinical diagnosis was made by the ward consultant. A
total of 31 patients with idiopathic Parkinson's disease parti-
cipated (mean age  58:4 years; SD  9:8; range: 37±72
years), 4 of these patients were untreated at the time of
study. Possible multiple system atrophy was diagnosed in
patients with a Parkinsonian syndrome, who showed little or
no response to levo-dopa therapy or cerebellar signs. Prob-
able multiple system atrophy was diagnosed in patients with
a Parkinsonian syndrome, who showed little or no levo-dopa
response and additional automonic failure, or cerebellar
and/or pyramidal signs, or pathological sphincter electro-
myogram (Quinn, 1994). In our patient sample, two patients
were diagnosed as possible multiple system atrophy and 4
patients as probable multiple system atrophy (mean age 
61:7 years; SD  8:2; range: 52±75 years). A third group of
6 in-patients were diagnosed with progressive supranuclear
palsy (mean age  68:5 years; SD  4:1; range: 62±75).
Diagnostic signs were vertical ocular palsy and/or pseudo-
bulbar palsy, progressive disease course, disease onset after
age 40 years, with either axial dystonia, rigidity, bradykine-
sia, disturbance in stance or gait, or frontal lobe signs (Lees,
1987). The results from these three patient groups were
compared to those of a control group (n  33), which was
made up of patients with no clinically determined central
nervous disorders (mean age  54:5 years; SD  8:5;
range: 40±72 years). Care was taken to select control
patients so that they were similar to the patient groups
with respect to age, gender and socio-economic status.
Any further CNS-acting drugs taken by the patients were
recorded.
Each patient underwent a detailed ophthalmological
examination prior to participation and they wore their full
optical correction during testing. Six additional patients
were excluded from the study owing to lens opacity or
other opthalmological disorders.
2.2. Stimuli
The stimulus set-up for electrophysiological and psycho-
physical testing is presented schematically in Fig. 1. The
visual stimuli were created on a Visual Stimulus Generator
(VSG 2/3) graphics board (Cambridge Research Systems,
Kent, UK) and displayed on a high-resolution color monitor
(Eizo; Japan). The voltage determining the luminance of the
stimuli was produced with 14-bit digital-to-analogue
converters. Correction of the luminance gamma function
of the display was calculated using a spectral photometer
(Spectra 704; USA) and stored in lookup tables (LUTs). The
mean luminance was 40 cd/m2. The ¯ash stimulus consisted
of a full-®eld luminance pro®le that was temporally modu-
lated at 10 Hz. In all other conditions, sinewave gratings
were used as stimuli for both electrophysiology and psycho-
physics. For the psychophysical measurements, circular
patches of sinewave grating (diameter 48) with constant
orientation (horizontal) and spatial frequency (4 cycles/
deg) but differing in contrast were presented simultaneously
for 200 ms, one in each visual ®eld 48 eccentric to ®xation
(Fig. 1). Reference contrast levels for psychophysics were
0% (detection threshold), 10.0, 20.0 and 40.0 and 80.0%
Michelson contrast; for electrophysiology they were 6.25,
12.5, 25, 50, and 100%. Thus, although the contrast values
were not identical they spanned a similar range for psycho-
physics and electrophysiology. The spatial phase of the grat-
ings was temporally modulated at a rate of 6.5 Hz with a
squarewave (electrophysiology) or sinewave (psychophy-
sics) temporal pro®le.
2.3. Electrophysiological recordings
The electroretinogram was recorded in each eye by
placing thin wire electrodes (Dawson et al., 1979) into the
conjunctival sac near the lower limbus. Reference electro-
des were gold cup electrodes ®lled with electrolytic paste
(TECA, Pleasantville, NY) and attached to the outer canthi.
This position was selected to minimize the effect of cortical
potentials arising along the scalp. Visually evoked poten-
tials were recorded from the scalp at Pz and referenced to a
frontal electrode at FPz (Jasper's 10±20 system). The
patient's left ear lobe was grounded. Electrode impedance
was measured and was not allowed to exceed 2.5 kV. The
analogue signals were ampli®ed with a commercially avail-
able EEG ampli®er system (Toennies, Germany), using a
time constant of 0.1 s and a upper cutoff frequency of 70 Hz.
The analogue signals were then passed to analogue-to-digi-
tal converters sampling every 2.5 ms. The Fourier spectrum
of the resultant signals was computed and the magnitude at
the reversal rate was extracted.
The patient ®xated a center ®xation cross and binocularly
viewed, with natural pupils, the patterns while ERGs and
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Fig. 1. Schematic illustration of the stimuli used in the experiments. For
more details see text.
VEPs were recorded (Fig. 1). The viewing distance was
constant at 57 cm. Eye blinks and eye movements were
detected via an amplitude threshold (. 100 mV) and data
from these trials were rejected. A minimum of 160 repeti-
tions was conducted per condition.
2.4. Psychophysical procedure
All subjects binocularly viewed, with natural pupils, the
stimulus display from a distance of 114 cm. The participant
was comfortably seated in an examination chair and rested
his or her head and arms on appropriately positioned rests.
The patients were instructed to direct their gaze to the center
of the display, where the ®xation cross was displayed during
each trial. Each measurement consisted of 150 trials (5
reference contrast levels, 30 trials per level). Each trial
was announced by a computer generated sound presented
200 ^ 100 ms prior to stimulus onset, at which time the
®xation cross was also presented. This was followed by
simultaneous presentation of reference and test stimuli
(Fig. 1). The stimulus duration was 200 ms and the onset
and offset of contrast was abrupt. The participants
responded by indicating which stimulus had the higher
contrast. In cases where only one stimulus was visible,
they were asked to indicate whether the stimulus appeared
on the left or right side of the display.
All 4 psychophysical measurements were conducted in a
single session. A suf®cient number of practice trials was
performed to assure that the patient understood the task
and became acquainted with the response box (psychophy-
sics). Electrophysiological data were usually collected on
the same day.
The methods used to determine psychophysical thresh-
olds have been described earlier (Tebartz Van Elst et al.,
1997). Brie¯y, an adaptive search algorithm, Best-PEST
(Lieberman and Pentland, 1982), was used to determine
thresholds for each of four reference contrast levels. Each
`staircase' was controlled by the PEST routine, which
started at the highest possible test contrast level (approach-
ing 100%) and selected one of 80 possible contrast levels.
Reaction times (RT) were also determined using a func-
tion that accesses the graphics processor, which timed the
duration between the stimulus onset and the response (press-
ing one of two buttons). We thus could achieve temporal
resolution of 10 ms (i.e. the duration of the buildup of each
line on the display). The subjects were given 2 s to respond.
If the subject did not respond within the speci®ed time, the
next trial was presented. The lapsed trial was placed back
into the trial pool and performed at a later point in the run.
2.5. Data analyses
Analyses of variance for repeated measures were
performed on the logarithms of detection and discrimination
threshold data, as well as on the amplitudes of the ERG and
VEP data. Reaction times were also statistically analyzed.
The main effects and interactions were determined for the
following factors: patient group, spatial frequency, and the
reference contrast level (detection threshold, four supra-
threshold contrast levels). Correlations between psychophy-
sical, electrophysiological and clinical data were also
calculated.
3. Results
3.1. Electroretinograms
The results for the electroretinographic data are summar-
ized in Fig. 2. The amplitude of the second harmonic
response in the electroretinogram is plotted as a function
of the stimulus contrast. The leftmost curves show the
best-®tting power functions, for patients and controls sepa-
rately, for the condition of full-®eld ¯icker modulation
(Flash), the centrally displayed curves show power func-
tions for the low spatial frequency condition (0.5 cycles/
degree) and the rightmost curves present these functions
for the medium spatial frequency condition (4 cycles/
degree). Over all conditions tested, ERG amplitudes
increase with increasing stimulus contrast. The shapes of
these `contrast response' functions varies for the three
spatial frequencies tested. Flash ERG amplitudes increase
as a compressive function of contrast, whereas pattern ERG
amplitude increases as an expansive function of contrast.
The derived maximal response levels and exponents are
shown in Table 2.
An analysis of variance was performed to assess the
effects of experimental group, stimulus contrast and spatial
frequency. The eye of acquisition (left, right) had no signif-
icant effect on the ERG amplitudes, and is treated as a
repeated within-subject variable in the analysis of variance.
The main effect of experiment group was highly signi®cant
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Fig. 2. Amplitude of the second harmonic response in the electroretino-
gram (ERG) as a function of stimulus contrast (plotted on log scale). The
curves show the best ®tting power functions for the results from Flash and
patterned stimulation (low and high spatial frequency). The different
symbols present the results for the four patient groups (see inset). Error
bars give 11 SE.
(F1; 71  8:92; P , 0:004), as were the effects of spatial
frequency (F2; 142  156:8; P , 0.0001) and stimulus
contrast (F4; 284  629:7; P , 0:0001). The interaction
between the effects of spatial frequency and contrast
(F8; 568  90:0; P , 0:0001), as well as between experi-
mental group and contrast (F4; 284  10:7; P , 0:0001)
were highly signi®cant. These interactions substantiate the
impression given in Fig. 2 and Table 2 that the contrast
response functions differed over spatial frequency and
were more shallow for the patients compared to the control
subjects. To eliminate any possible effect of visual acuity on
the ERG amplitudes, we performed the ANOVA for data
from subjects with an acuity of 0.8 or better. This analysis
indicated that the main effect of patient group remained
signi®cant (F1; 51  6:18; P , 0:017). Thus, the effects
of Parkinson's disease on ERG amplitudes cannot be
explained solely by a loss in visual acuity.
A further analysis of variance was performed to test the
effect of the type of Parkinsonian syndrome. Table 2
presents the Rmax, exponent and correlation values for the
three patient groups separately. As above, data collected
from either eye were pooled. The main effect of the type
of Parkinsonian syndrome was not signi®cant
(F2; 34  0:34; n.s.), nor were any of the ®rst- or
second-order interactions.
3.2. Visually evoked potentials
The results of the visually evoked potential (VEP) analy-
sis are shown in Fig. 3. The amplitude of the response
component at the second harmonic frequency is plotted as
a function of stimulus contrast. The different symbols
present the results of the different patient groups. The func-
tions plot the best ®tting hyperbolic ratios, which provide a
good description of the relationship between stimulus
contrast and neural response (Albrecht and Hamilton,
1982; Sclar et al., 1990). The best ®tting values for the
three parameters describing this function are given in
Table 3. VEP amplitude increases with increasing contrast
level. At higher contrast levels the VEP amplitude begins to
saturate. There is no obvious difference between the differ-
ent patient groups. If anything, the patients with Parkinson's
disease show slightly larger VEP amplitudes compared to
the control patients. Interestingly, the six patients with
multiple system atrophy show the largest VEP amplitudes
for patterned stimulation.
An analysis of variance was performed to assess the
effects of spatial frequency, contrast and patient group on
the amplitude of the VEP. This yielded a signi®cant effect of
spatial frequency (amplitudes decreasing with increasing
spatial frequency; F2; 6  3:41; P , 0:04) and contrast
(amplitudes increasing with increasing contrast;
F4; 12  97:8; P , 0:0001). The interaction term
between spatial frequency and contrast was also signi®cant
(F8; 24  7:0; P , 0:0001), indicating that the contrast
response functions differed for the different spatial
frequency conditions. Inspection of the results indicated
that this effect is mostly related to the difference between
the ¯ash and patterned stimulation conditions. The main
effect of experimental group (patients vs. controls) was
not signi®cant.
3.3. Contrast thresholds and contrast discrimination
The results of the psychophysical measurements are
shown in Fig. 4, which plots the logarithm of the contrast
discrimination threshold as a function of the stimulus
contrast. The different symbols present the results for the
four patient groups. The ®tted functions are hyperbolic
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Fig. 3. Amplitude of the visually evoked potential (VEP) measured at the
scalp over posterior cortex as a function of the stimulus contrast (log scale).
The different curves show the best ®tting hyperbolic ratios. Otherwise as in
Fig. 2.
Table 2
Results of curve ®ts describing the relationship between ERG amplitude and stimulus contrast. The function ®t to the data had the following form:
R  Rmax p Ca; Rmax  maximal response (in mV), a  exponent of power function, R2  coefficient of determination
Patient group PD MSA PSP CON
Rmax a R
2 Rmax a R
2 Rmax a R
2 Rmax a R
2
Flash 2.75 0.744 0.998 3.54 0.806 0.999 2.90 0.819 0.992 3.2 0.702 0.999
Pattern (0.5 cycles/deg) 1.27 1.14 0.979 1.37 1.256 0.997 1.04 1.02 0.975 1.7 1.265 0.984
Pattern (4.0 cycles/deg) 0.82 1.21 0.998 0.57 0.927 0.971 0.58 1.03 0.962 1.3 1.344 0.999
ratios. All groups show contrast discrimination thresholds
that increase with increasing stimulus contrast. There is a
consistent difference between thresholds measured in the
patients with Parkinson's disease compared to the control
patients. The elevation in detection thresholds persists in the
suprathreshold contrast discriminations. This result
con®rms an earlier observation from our laboratory (Tebartz
Van Elst et al., 1997). Note that the patients with supra-
nuclear palsy have the most dif®culty with the psychophy-
sical tasks, whereas patients with multiple system atrophy
show results similar to those of the control patients.
An analysis of variance was conducted to examine the
main effects of patient group, spatial frequency and contrast
level. The effect of group was highly signi®cant
(F3; 58  4:8; P , 0:005). Post-hoc tests (Bonferroni/
Dunn) indicated that these differences were due to the rela-
tively high contrast thresholds exhibited by the PSP patients
(Fig. 4). The effect of spatial frequency was not signi®cant
(F1; 3  2:2; n.s.), whereas the effect of contrast was
highly signi®cant (F4; 12  78:9; P , 0:0001). The inter-
action between patient group and contrast level was not
signi®cant (F12; 232  0:7; n.s.), suggesting that the
effect of reference contrast level was similar over the 4
patient groups.
We further examined the possible relationship between
the electrophysiological ®ndings and the psychophysical
thresholds. The variables in question are those that signi®-
cantly differed across the patient groups. Thus we calculated
correlation coef®cients between the pattern ERG amplitudes
at the highest contrast level and the psychophysical thresh-
olds. No signi®cant correlations were found between these
variables for the ¯ash and patterned stimulation condition
with a low spatial frequency (0.5 cycles/degree). There was,
however, a signi®cant negative correlation between the
ERG amplitudes for 4.0 cycles/degree patterned stimulation
at the highest contrast level and the psychophysical thresh-
olds for this spatial frequency (r  20:27; d:f:  60;
P , 0:03), but not between the VEP amplitude at the high-
est contrast and thresholds (r  20:096; d:f:  60; n.s.).
Although the former correlation is only moderate in magni-
tude, it does suggest that pattern ERG responses and
psychophysical thresholds are affected by a common
mechanism.
3.4. Reaction times
The results of the reaction time measurements are shown
in Fig. 5. The logarithm of reaction time (in seconds) is
plotted as a function of stimulus contrast for the two condi-
tions of patterned stimulation. As in the other ®gures, the
different symbols present the results of the four patient
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Fig. 4. Log of the contrast discrimination thresholds as a function of the
reference contrast on log coordinate. The curves show the best ®tting
hyperbolic ratios. Symbols and error bars as in Fig. 2.
Fig. 5. Log reaction times (RT) as a function of the reference contrast on
log coordinate. Symbols and error bars as in Fig. 3.
Table 3
Results of curve ®ts describing the relationship between VEP amplitude and stimulus contrast. The function ®t to the data was as follows:
R  Rmax{Ca=Ca 1 C50a}; Rmax  maximal response (in mV), a  exponent of hyperbolic ratio, C50  semi-saturation constant, R2  coefficient of deter-
mination
Patient group PD MSA PSP CON
Rmax a C50 R
2 Rmax a C50 R
2 Rmax a C50 R
2 Rmax a C50 R
2
Flash 4.9 1.2 0.7 0.999 4.91 1.21 0.813 0.999 9.35 3.38 0.839 0.99 7.7968 2.3386 0.812 0.995
Pattern (0.5 cycles/deg) 3.28 1.18 0.999 0.99 3.87 2.35 0.9 0.987 6.08 1.64 0.99 0.99 2.5 3.23 0.71 0.993
Pattern (4.0 cycles/deg) 1.37 1.88 1.19 0.998 4.6 1.6 1.65 .995 1.08 3.2 0.7 0.99 1.62 2.68 0.7 0.995
groups. Reaction times in the detection task with reference
contrast equal to zero are shown as the leftmost points for
each spatial frequency condition. There is a clear tendency
for the patients with multiple system atrophy to exhibit the
longest reaction times. Also patients with Parkinson's
disease tended to show longer reaction times compared to
the control patients. The reaction times are greatest at detec-
tion threshold level and decline gradually with increasing
suprathreshold contrast.
An analysis of variance revealed a signi®cant main effect
of stimulus contrast (F4; 12  27:1; P , 0:0001), but no
signi®cant effects for spatial frequency (F1; 3  0:3; n.s.)
and patient group (F3; 56  2:3; n.s.). Although the differ-
ences in log RT look substantial in Fig. 5 the variability
across patients is also substantial. As such the trends do
not reach signi®cance levels.
3.5. Correlation with clinical course
The disease course was evaluated with help of the
Webster score (Webster, 1966). The results for each patient
are shown in Table 1. The mean Webster score signi®cantly
differed over the patient groups (F2; 39  4:3; P , 0:02).
The mean Webster score for the patients with Parkinson's
disease was 9.6 (SD  5:2), for the patients with multiple
system atrophy 17.2 (SD  7:4) and for the patients with
supranuclear palsy 13.75 (SD  9:9). The Webster score
was used as an index of pathology to correlate with the
dependent variables under study here. None of the electro-
physiological variables correlated signi®cantly with the
Webster score. Signi®cant correlations were, however,
evident between the psychophysically determined contrast
thresholds and the Webster score (spatial frequency  0:5
cylces/degree; r  0:43, P , 0:01). Also the log of reaction
times at threshold signi®cantly correlated with the Webster
score (spatial frequency  0.5 cylces/degree; r  0:49,
P , 0:01; spatial frequency  4:0 cylces/degree;
r  0:48, P , 0:01). Thus, patients with more severe symp-
toms tended to perform more poorly in the psychophysical
task and required more time to respond.
In our patient sample we had 4 untreated patients, who
had not received any l-dopa medication during the investi-
gation. Direct comparisons between untreated and medi-
cated Parkinson's patients are, however, confounded by a
number of clinical variables (age, illness duration, etc.).
Despite these precautions we compared the most important
ERG and psychophysical data between treated and
untreated PD patients, but could not ®nd any signi®cant
differences. However, due to the small size of the untreated
patient group, these observations have to be interpreted with
caution.
4. Discussion
The present results indicate that the retinal processing of
stimulus contrast is impaired in Parkinson's disease. The
amplitude of the ERG for low and medium spatial frequen-
cies is signi®cantly reduced in these patients, whereas
contrast detection thresholds and contrast discrimination
thresholds were signi®cantly elevated. These threshold
elevations appear to be a result of an diminished contrast
transduction in the retina.
4.1. Electrophysiological ®ndings
The amplitudes of the ERGs to patterned stimulation are
signi®cantly reduced in Parkinson's disease (Fig. 2). This
®nding substantiates and extends the earlier results of other
groups concerning alterations in the ERG in these patients
(Nightingale et al., 1986; Gottlob et al., 1987). The spatial
frequency selectivity of the reduction in ERG amplitude
(Stanzione et al., 1989; Bodis-Wollner, 1990) points to a
speci®c neural mechanism rather than to a global effect.
The more pronounced effect at a spatial frequency of 4
cycles/degree in the present study (Fig. 2) supports this
claim.
We also studied the effect of stimulus contrast on the
ERG amplitudes to determine the extent to which the
contrast response function is altered by the Parkinsonian
pathology (Fig. 2). The best ®tting power functions yielded
accurate approximations of the relationship between ERG
amplitude and contrast. For all patients tested these func-
tions were compressive for unpatterned stimulation (¯ash)
and expansive for patterned stimulation (Table 2). The
exponents (slopes) of the power functions were consistently
lower in the patients with Parkinson's disease and supra-
nuclear palsy compared to the control patients. This effect
was much less pronounced in patients with multiple system
atrophy, suggesting that the visual system is not affected in
this disorder (cf.Tebartz Van Elst et al., 1997). The visually
evoked potential recorded over posterior cortex showed a
compressive contrast response function (Fig. 3). These func-
tions could be approximated by hyperbolic ratios and the
parameters of these functions were presented in Table 3.
Overall the VEPs did not signi®cantly differ over the four
patient groups studied. This lack of signi®cant difference
could be related to the greater variability of amplitudes
across patients within each group. It might also re¯ect the
fact that some form of cortical contrast gain control has
taken place. The reduced retinal contrast signals could be
partially compensated for by cortical mechanisms, which
adjust their contrast gain to extract more information. Surely
such a compensation can only be partial, since the signal-to-
noise ratio will de®ne the limits of perceptual discrimina-
tion. In an earlier study (Tebartz Van Elst et al., 1997), we
could demonstrate that psychophysical adaptation processes
appear to be intact in Parkinson's patients. Such adaptive
gain control mechanisms could be useful to ameliorate the
effects of impaired retinal signal transmission on vision.
4.2. Clinical ®ndings and visual pathology
One of the motivations for the present study was to test
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the usefulness of electrophysiological measures of visual
response in the differential diagnosis of Parkinsonian disor-
ders. As we have reported earlier (Tebartz Van Elst et al.,
1997), psychophysically determined contrast detection
thresholds can differentiate between Parkinson's disease
and multiple system atrophy. The results shown in Fig. 4
support this claim. The differences between the patients
with Parkinson's disease and multiple system atrophy are,
however, less pronounced than those found in our earlier
study. We relate this to the ®nding that the patients with
multiple system atrophy in the present study had more
pronounced psychomotor impairments, as indexed by
signi®cantly higher Webster scores. Since the psychophysi-
cal tasks demand attention and vigilance, the more severe
disease course in patients with multiple system atrophy
could have negatively affected their psychophysical perfor-
mance. On the other hand, patients with supranuclear palsy
exhibited the highest thresholds (Fig. 4) and the highest
Webster scores. To our knowledge, this is the ®rst report
on contrast sensitivity and visual electrophysiolology on
patients with progressive supranuclear palsy. Interpretation
of the ®ndings are dif®cult, since these patients also have
impaired oculomotor control, which could have contributed
to their relatively poor psychophysical performance. Over-
all, the ®ndings suggest that electrophysiological measures
of visual function could contribute to the differential diag-
nosis of Parkinson's disease. However, as with other diag-
nostic tools, these measures should be used together with
clinical ratings to differentiate between the different akinetic
syndromes.
4.3. Correlation between electrophysiological and
psychophysical measures
The correlation between the electrophysiological and
psychophysical measures was not robust. One critical corre-
lation between ERG amplitude and psychophysical thresh-
olds was signi®cant. This negative correlation indicates that
patients with lower ERG amplitudes at maximum contrast
exhibit thresholds that are higher than average and vice
versa. This trend was signi®cant, however, only for the
stimulus with a spatial frequency of 4 cycles/degree. The
lack of correlation between the VEP amplitudes and thresh-
olds could be related to the larger noise levels associated
with the VEP, but also to the smaller variability ± within and
across the groups.
4.4. Relationship to earlier studies
The spatial-frequency selective reduction in the ampli-
tude of the pattern ERG suggests that the receptive ®eld
structure of dopaminergic amacrine, horizontal and inter-
plexiform neurons is altered. Under similar conditions of
light adaptation, the ganglion cells of the Parkinsonian
retina could display larger central summation areas as a
consequence of reduced surround inhibition (Bodis-Woll-
ner, 1990). Ikeda and coworkers put forth a model of the
receptoral and postreceptoral processing of visual contrast
in the Parkinsonian visual system. They suggest that the
interplay between `on' and `off' center receptive ®elds of
retinal ganglion cells can be disturbed by the imbalance
between dopaminergic, GABAergic and glycinergic recep-
tors in amacrine and interplexiform neurons (Ikeda et al.,
1994). Similar concepts have been put forth by other groups
to explain the shift in the contrast sensitivity function for
detecting sinewave gratings in patients with Parkinson's
disease (Bodis-Wollner et al., 1987; Masson et al., 1993)
and drug-induced Parkinsonism (Bulens and Meerwaldt,
1989), as well as changes in peripheral (Harris et al.,
1992) and perifoveal (Tebartz Van Elst et al., 1997) contrast
matching performance in Parkinson's disease.
The alterations in pattern-ERGs can also be accounted for
by a de®ciency in retinal dopaminergic processing. De novo
idiopathic Parkinson's patients exhibit pattern ERGs and
VEPs with signi®cantly longer latencies, and this difference
is reduced by l-dopa therapy (Peppe et al., 1992; Peppe et
al., 1995). Healthy subjects treated with haloperidol, a dopa-
mine antagonist, show pattern ERGs that are more delayed
than VEPs (Stanzione et al., 1991). In a 5 year follow-up
study of Parkinson's patients (Ikeda et al., 1994), ¯ash and
pattern-ERG responses exhibited amplitudes that were more
reduced and latencies that were greater at follow-up. The
spatial frequency selectivity of the reduction in ERG ampli-
tudes evident in a recent study (Tagliati et al., 1996) and the
present one (Fig. 2) support the contention that the retinal
dopamine de®ciency evident in Parkinson's disease has a
speci®c effect.
The contrast response functions of steady-state VEP-
amplitudes did not signi®cantly differ between patients
with Parkinson's disease and controls (Fig. 3). With transi-
ent evoked potentials other groups have found a signi®cant
increase in latency (Bodis-Wollner and Yahr, 1978; Gawel,
1981; Mintz et al., 1981). Gottlob et al. (1987) also found
signi®cantly increased latencies in transient VEPs in
patients with Parkinson's disease, although the amplitudes
were within the normal range. It should be noted, however,
that an increased latency in the visually evoked cortical
response need not imply that the site of this delay is in the
visual cortex. To the contrary, the delays found in the ERGs
appear to cause the delays found in the cortical VEP.
4.5. Summary
We have studied the contrast-amplitude relationships at
three levels in the visual system of patients with idiopathic
Parkinson's disease and related neurodegenerative disor-
ders. Our ®ndings support and extend those of earlier studies
which indicate a reduction in ERG-amplitudes for medium
spatial frequencies. A signi®cant decline in the slope of the
ERG-amplitude vs. contrast functions in patients with
Parkinson's disease, along with the absence of an effect in
the visually evoked cortical potential, suggest that the site of
the impairment is in the retina. The signi®cant correlation
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between within-subject averaged ERG-amplitudes and
psychophysical contrast discrimination thresholds also
lends support to this claim.
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